Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir to improve influenza vaccine immunity in CMV-positive older adults
2011-000092-13Phase 4Completed
- Start
- Apr 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of valaciclovir in cytomegalovirus disease (CMV) and influenza (3 arms). Primary endpoints: Magnitude of CMV-specific CD4+ T-cell immune response, Magnitude of CMV-specific CD8+ T-cell immune response and 3 more. Started Apr 2011; status: completed.
02
Drugs
valaciclovir
03
Conditions
cytomegalovirus disease (CMV)influenza
Beyond the preview
Go deeper on 2011-000092-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000092-13.